Displaying 61 - 80 of 465
Statement of Chair Lina M. Khan on the Ruling by Judge Denise L. Cote Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC et al
Date
Today, U.S. District Court Judge Denise Cote held “Pharma Bro” Martin Shkreli liable for antitrust claims brought by the Federal Trade Commission and a group of seven state enforcers. Finding that...
FTC Approves Final Order Requiring Generic Drug Marketers ANI Pharmaceuticals, Inc. and Novitium Pharma LLC to Divest Rights and Assets to Generic Sulfamethoxazole-Trimethoprim Oral Suspension and Generic Dexamethasone Tablets
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that ANI Pharmaceuticals, Inc.’s $210 million acquisition of Novitium Pharma LLC violated...
FTC Appoints Substitute Monitor
Date
The Federal Trade Commission has appointed Gregory Heltzer as the substitute monitor to oversee the Decision and Order In the Matter of Corpus Christi Polymers LLC, et al. because the original monitor...
Corpus Christi Polymers LLC, et al., In the Matter of
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that three PET resin producers’ proposed $1.1 billion joint acquisition out of bankruptcy of an under-construction PET production facility would violate federal antitrust law.
Type of Action
Administrative
Last Updated
FTC Approves Modifications to Bristol Meyers Squibb Divestiture Agreement
Date
The Federal Trade Commission has approved certain modifications to Bristol Meyers Squibb’s, or BMS’s, Divestiture Agreements that the FTC approved and incorporated into its order as part of a consent...
FTC Requires Generic Drug Marketers ANI Pharmaceuticals, Inc. and Novitium Pharma LLC to Divest Rights and Assets to Two Generic Products as Condition of Merger
Date
The Federal Trade Commission will require generic drug marketers ANI Pharmaceuticals, Inc. and Novitium Pharma LLC to divest, to Prasco LLC, ANI’s development rights to one generic drug used to treat...
FTC Announces Tentative Agenda for November 18 Open Commission Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, November 18, 2021. The open meeting will begin at 1pm ET and...
Nov18
Open Commission Meeting – November 18, 2021
Agenda items: Presentation on Criminal Referrals and Partnerships and Motion to Issue Commission Statement, 6(b) Study on Supply Chain Disruptions
FTC Requests Public Comment on Petition from Sartorius Stedim Biotech S.A. for Agency Approval of Its Acquisition of Chromatography Equipment Business of Novasep Process SAS
Date
The Federal Trade Commission is currently accepting public comments on an application by Sartorius Stedim Biotech S.A. for the Commission to approve its acquisition of t he chromatography equipment...
Federal Register Notice
Resident Home, LLC; Analysis of Proposed Consent Order To Aid Public Comment
Date
FTC Orders “Made in USA” Repeat Offender to Pay Funds
Date
Resident Home LLC and owner Ran Reske, will pay $753,000 to settle FTC charges that they made false, misleading, or unsupported advertising claims that their imported DreamCloud mattresses were made...
Oral Remarks of Commissioner Christine S. Wilson Regarding Care Labeling Rule, Repair Restrictions Imposed by Manufactures and Sellers, and Prior Approval and Prior Notice Provisions in Merger Cases
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
R511915
File
HeidelbergCement AG, et al., In the Matter of
The Federal Trade Commission is seeking to block Lehigh Cement Company LLC’s $151 million acquisition of rival Pennsylvania-based cement producer Keystone Cement Company, alleging the deal would harm regional competition in the market for the key ingredient used to make concrete. The FTC alleges that the acquisition would harm competition in the market for gray portland cement in eastern Pennsylvania and western New Jersey, reducing the number of significant competitors from four to three. The administrative trial was scheduled to begin on Nov. 2, 2021, but on June 4, 2021, the FTC announced that the parties have abandoned the transaction.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
2010006
Docket Number
9402
Case Status
Closed
Statement of Acting Bureau of Competition Director Maribeth Petrizzi Regarding Decision of Pennsylvania Cement Producers Lehigh Cement Company LLC and Keystone Cement Company to Abandon Their Proposed Merger
Date
Following the parties’ decision to abandon their proposed merger, Acting Bureau of Competition Director Maribeth Petrizzi made this statement: “This is great news for cement customers in eastern...
Statement of Commissioners Christine S. Wilson and Noah Joshua Phillips Regarding the Federal Trade Commission's Report to Congress on Rebate Walls
Date
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Federal Register Notice
16 CFR Part 305: Energy Labeling Rule; Notice of Proposed Rulemaking; Request for Public Comment (CAC Range Updates)
Date
Displaying 61 - 80 of 465